National Healthcare Properties, Inc. NHP
15.95 USD +0.71 (+4.66%)
At closeNov 9, 2026, 4:00 PM EST
15.95 0.00 0.00%
After hours · Nov 9, 4:00 PM ET
14.83 Day range 15.99
11.25 52-week range 17.46
- YTD
- +32.92%
- 1 year
- +32.92%
News
seekingalpha.com National Healthcare Properties, Inc. (NHP) Q3 2026 Earnings Call Transcript National Healthcare Properties, Inc. ( NHP ) Q3 2026 Earnings Call November 5, 2026 10:00 AM EST Company Participants Michael Ozuna - Director of Investor Relations Michael Anderson - President, CEO…
benzinga.com National Healthcare Q3 2026 Earnings Call Transcript National Healthcare (NASDAQ:NHP) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought…benzinga.com National Healthcare Q3 FFO $0.19, Inline, Sales $103.062M Beat $93.583M Estimate National Healthcare (NASDAQ:NHP) reported quarterly earnings of $0.19 per share which met the analyst consensus estimate. This is a 29.63 percent decrease over earnings of $0.27 per share from the…
globenewswire.com National Healthcare Properties Reports Third Quarter 2026 Results SHOP Same Store Cash NOI increased 13.6% year-over-year $664 million of 2026 SHOP acquisitions completed or under definitive agreement SHOP Same Store Cash NOI growth guidance increased by 100bps at…benzinga.com Wells Fargo Maintains Overweight on National Healthcare, Lowers Price Target to $18 Wells Fargo analyst James Feldman maintains National Healthcare (NASDAQ:NHP) with a Overweight and lowers the price target from $19 to $18.
benzinga.com This Electra Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday Analysts initiated coverage on NHP (Outperform, $20), OIG (Buy, $13), ETRA (Overweight), AHR (Strong Buy, $62).benzinga.com Raymond James Initiates Coverage On National Healthcare with Outperform Rating, Announces Price Target of $20 Raymond James analyst David Rodgers initiates coverage on National Healthcare (NASDAQ:NHP) with a Outperform rating and announces Price Target of $20.
